ArticleJournal of cancer research and clinical oncology2024

The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinoma.

Anne Olbrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.